Loading...
XSHE300401
Market cap1.08bUSD
Jan 14, Last price  
14.62CNY
1D
1.67%
1Q
2.74%
Jan 2017
-3.74%
IPO
558.56%
Name

Zhejiang Garden Biopharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:300401 chart
P/E
41.02
P/S
7.21
EPS
0.36
Div Yield, %
0.98%
Shrs. gr., 5y
4.59%
Rev. gr., 5y
10.64%
Revenues
1.09b
-22.78%
125,486,953133,015,533197,288,376320,961,779225,996,938184,386,509158,840,437151,221,057329,093,755419,868,699660,216,835718,384,535614,894,4401,117,099,8931,417,511,8161,094,651,559
Net income
192m
-49.87%
16,957,40316,770,06868,848,503147,685,23083,972,72636,432,88637,287,17912,074,69943,772,785130,403,327307,408,646343,706,532263,216,164483,766,455383,722,581192,348,873
CFO
160m
-57.57%
00081,096,70241,950,51365,130,291042,519,38149,266,348146,743,897252,735,039366,536,248416,571,982504,029,922377,039,761159,984,577
Dividend
May 15, 20240.071 CNY/sh
Earnings
May 06, 2025

Profile

Zhejiang Garden Bio-chemical High-tech Co., Ltd., together with its subsidiaries, manufactures and supplies vitamin D3, cholesterol, and calcifediol in China. Its products have applications in food additives, nutrition and health products, and medicine. The company was founded in 2000 and is based in Dongyang, China.
URL
http://www.hybiotech.com/
IPO date
Oct 09, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,094,652
-22.78%
1,417,512
26.89%
Cost of revenue
802,922
917,619
Unusual Expense (Income)
NOPBT
291,730
499,893
NOPBT Margin
26.65%
35.27%
Operating Taxes
18,696
58,760
Tax Rate
6.41%
11.75%
NOPAT
273,033
441,133
Net income
192,349
-49.87%
383,723
-20.68%
Dividends
(77,141)
(102,147)
Dividend yield
1.09%
1.31%
Proceeds from repurchase of equity
(90,391)
BB yield
1.27%
Debt
Debt current
408,679
625,724
Long-term debt
923,271
186,663
Deferred revenue
42,525
63,598
Other long-term liabilities
93,332
1
Net debt
(237,269)
189,684
Cash flow
Cash from operating activities
159,985
377,040
CAPEX
Cash from investing activities
Cash from financing activities
1,040,336
43,990
FCF
228,116
100,534
Balance
Cash
1,502,870
554,909
Long term investments
66,349
67,793
Excess cash
1,514,487
551,827
Stockholders' equity
2,560,229
2,618,453
Invested Capital
2,846,450
2,846,249
ROIC
9.59%
16.47%
ROCE
6.62%
14.71%
EV
Common stock shares outstanding
601,090
543,333
Price
11.81
-17.93%
14.39
0.07%
Market cap
7,098,876
-9.20%
7,818,559
0.07%
EV
6,861,606
8,008,243
EBITDA
425,089
560,877
EV/EBITDA
16.14
14.28
Interest
38,713
21,819
Interest/NOPBT
13.27%
4.36%